Tyrosine Kinases as Druggable Targets in Cancer
Protein tyrosine kinase (PTK) deregulation contributes to growth of cancer and many other diseases. The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the deregulated PTKs, such as epidermal growth factor receptor (EGFR) in non-small-cell lung cancer (NSCLC) and Bcr-ABL...
Zapisane w:
Kolejni autorzy: | Ren, Huan (Redaktor) |
---|---|
Format: | Elektroniczne Rozdział |
Język: | angielski |
Wydane: |
IntechOpen
2019
|
Hasła przedmiotowe: | |
Dostęp online: | DOAB: download the publication DOAB: description of the publication |
Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|
Podobne zapisy
-
Pancreatic Cancer Molecular Mechanism and Targets
Wydane: (2012) -
Molecular Targets of CNS Tumors
Wydane: (2011) -
Oncogenomics and Cancer Proteomics Novel Approaches in Biomarkers Discovery and Therapeutic Targets in Cancer
Wydane: (2013) -
Novel Therapeutic Concepts in Targeting Glioma
Wydane: (2012) -
Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma
Wydane: (2012)